Device Trial Radar · NCT01173965
Endometrial Ablation With Non-hysteroscopic Methods
Last checked: Nov 20, 2026Latest source record: Jul 12, 2012 (this record)Source: ClinicalTrials.govMethods & limitations
Sponsor
- Lead sponsor
- Aristotle University Of ThessalonikiAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Aug 3, 2010
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- Female only, from 30 years, up to 49 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Endometrial ablation in women with dysfunctional uterine bleeding using second generation ablation devices is a common widespread therapeutic approach. This study aims to prove that amenorrhoea rates using Novasure are higher than those observed in microwave endometrial ablation, one year following intervention.
Conditions
- Dysfunctional Uterine Bleeding
Interventions
MEADevice
Microwave endometrial ablation device
NovasureDevice
Bipolar impedence control system
Primary outcomes
What the sponsor says the trial is designed to measure.
- Amenorrhoea rates one year after intervention
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
First Dept. Of ObGyn, Medical School Aristotle University of Thessaloniki, Papageorgiou Hospital
Thessaloniki, Thessaloniki, Greece
1 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.